186 related articles for article (PubMed ID: 2839813)
1. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.
Losonsky GA; Rennels MB; Lim Y; Krall G; Kapikian AZ; Levine MM
Pediatr Infect Dis J; 1988 Jun; 7(6):388-93. PubMed ID: 2839813
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.
Midthun K; Pang LZ; Flores J; Kapikian AZ
J Clin Microbiol; 1989 Dec; 27(12):2799-804. PubMed ID: 2556433
[TBL] [Abstract][Full Text] [Related]
3. Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays.
Delem A; Vesikari T
J Med Virol; 1987 Mar; 21(3):231-8. PubMed ID: 3031200
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
5. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
[TBL] [Abstract][Full Text] [Related]
6. Serologic and mucosal immune response to rotavirus infection in the rabbit model.
Conner ME; Gilger MA; Estes MK; Graham DY
J Virol; 1991 May; 65(5):2562-71. PubMed ID: 1850029
[TBL] [Abstract][Full Text] [Related]
7. The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants.
Losonsky GA; Reymann M
J Infect Dis; 1990 Feb; 161(2):330-2. PubMed ID: 2153740
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
9. Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers.
Bernstein DI; Kacica MA; McNeal MM; Schiff GM; Ward RL
Antiviral Res; 1989 Dec; 12(5-6):293-300. PubMed ID: 2561335
[TBL] [Abstract][Full Text] [Related]
10. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
Green KY; Taniguchi K; Mackow ER; Kapikian AZ
J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis.
Brüssow H; Werchau H; Lerner L; Mietens C; Liedtke W; Sidoti J; Sotek J
J Infect Dis; 1988 Sep; 158(3):588-95. PubMed ID: 2842406
[TBL] [Abstract][Full Text] [Related]
12. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
13. Homotypic and heterotypic serum and milk antibody to rotavirus in normal, infected and vaccinated horses.
Browning GF; Chalmers RM; Sale CS; Fitzgerald TA; Snodgrass DR
Vet Microbiol; 1991 May; 27(3-4):231-44. PubMed ID: 1715620
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
16. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
Rennels MB; Losonsky GA; Shindledecker CL; Hughes TP; Kapikian AZ; Levine MM
Pediatr Infect Dis J; 1987 Mar; 6(3):260-4. PubMed ID: 3033593
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants.
Pichichero ME; Marsocci SM; Francis AB; Green JL; Disney FA; Rennels MB; Lewis ED; Sugarman L; Losonsky GA; Zito E
Vaccine; 1993; 11(7):747-53. PubMed ID: 8393606
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
